How has CorMedix's preferred stock, liquidation preference, value changed year-over-year?

CorMedix's preferred stock, liquidation preference, value increased by 27.4% year-over-year, from $4.43M to $5.64M.

What is the long-term trend for CorMedix's preferred stock, liquidation preference, value?

Over 5 years (2020 to 2025), CorMedix's preferred stock, liquidation preference, value has grown at a -95.3% compound annual growth rate (CAGR), from $23.67T to $5.64M.

CorMedix CRMD Preferred stock, liquidation preference, value

Preferred stock, liquidation preference, value at other companies

CitigroupC

$2.44B0.0%

AWK

American Water WorksAWK

$3M0.0%

EFC

Ellington Financial Inc.EFC

$230K-33.3%

CorMedixCRMD

$5.64M+27.4%

Ponce Financial Group, Inc.PDLB

$1,000.000.0%

Jefferies Financial GroupJEF

$500.00-97.1%

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockLiquidationPreferenceValue.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's preferred stock, liquidation preference, value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's preferred stock, liquidation preference, value?: CorMedix (CRMD) reported preferred stock, liquidation preference, value of $5.64M in Q1 2026.
How has CorMedix's preferred stock, liquidation preference, value changed year-over-year?: CorMedix's preferred stock, liquidation preference, value increased by 27.4% year-over-year, from $4.43M to $5.64M.
What is the long-term trend for CorMedix's preferred stock, liquidation preference, value?: Over 5 years (2020 to 2025), CorMedix's preferred stock, liquidation preference, value has grown at a -95.3% compound annual growth rate (CAGR), from $23.67T to $5.64M.